PM
Therapeutic Areas
Taiho Oncology Pipeline
| Drug | Indication | Phase |
|---|---|---|
| LONSURF (trifluridine/tipiracil) | Metastatic Colorectal Cancer, Metastatic Gastric Cancer | Approved |
| Azacitidine + Cedazuridine (oral) | Myelodysplastic Syndromes (inferred) | Phase 3 (inferred from ASH presentation) |
| Decitabine + Cedazuridine (oral) | Myelodysplastic Syndromes / Myeloid Malignancies (inferred) | Phase 3 (inferred from ASH presentation) |